Biopharmaceutical company
Issues related to excise tax Issues related to patient access
Issues related to pharmaceutical manufacturing
Issues related to treatment of endometriosis
Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019
Medicare Part D
H.R. 748 CARES Act - Issues related to COVID-19 relief
S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 Issues related to pharmaceutical manufacturing
Issues related to treatment of endometriosis
TAX - Taxation/Internal Revenue Code HCR - Health Issues MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of
BROWNSTEIN HYATT FARBER SCHRECK, LLP
1155 F Street NW, Suite 1200, Washington, DC, 20004, US
RUSSELL W. SULLIVAN LAURA JOHNSON BOLLIER ELIZABETH ANNE MAIER ALFRED MOTTUR ZACHARY PFISTER JEROME MURRAY NADEAM ELSHAMI DAVID PHILLIP COHEN ANDREW LITTMAN (Policy Dir, Sen Barbara Boxer; Chief of Staff, Sen Al Franken; Sr Counselor, HHS Sec Sylvia Matthews Burwell) EMILY FELDER
Policy Dir, Sen Barbara Boxer; Chief of Staff, Sen Al Franken; Sr Counselor, HHS Sec Sylvia Matthews Burwell